Trevi Therapeutics (TRVI) Current Leases (2019 - 2026)
Trevi Therapeutics' quarterly Current Leases came in at $318000.0 in Q1 2026, up 15.22% year-on-year from $276000.0 in Q1 2025, and up 3.58% quarter-over-quarter from $307000.0 in Q4 2025.
Trevi Therapeutics has reported Current Leases for 8 years, with the latest figure at $318000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 15.22% year-over-year to $318000.0; the trailing twelve-month figure through Mar 2026 stood at $318000.0 (up 15.22% YoY), and the FY2025 full-year result was $307000.0, up 20.87% from the prior year.
- Current Leases for Q1 2026 stood at $318000.0, up from $307000.0 in the prior quarter.
- The five-year high for Current Leases was $318000.0 in Q1 2026, with the low at $25000.0 in Q4 2022.
- Average Current Leases over 5 years is $172437.5, with a median of $153500.0 recorded in 2022.
- Year-over-year, Current Leases slumped 79.17% in 2022 and surged 636.0% in 2023.
- Tracing TRVI's Current Leases over 5 years: stood at $25000.0 in 2022, then surged by 636.0% to $184000.0 in 2023, then soared by 38.04% to $254000.0 in 2024, then increased by 20.87% to $307000.0 in 2025, then advanced by 3.58% to $318000.0 in 2026.
- The last three Current Leases figures came in at $318000.0 (Q1 2026), $307000.0 (Q4 2025), and $286000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | 318,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318,000.00 |
| Dec 31, 2025 | 307,000.00 |
| Jun 30, 2025 | 286,000.00 |
| Mar 31, 2025 | 276,000.00 |
| Dec 31, 2024 | 254,000.00 |
| Sep 30, 2024 | 62,000.00 |
| Jun 30, 2024 | 216,000.00 |
| Mar 31, 2024 | 198,000.00 |
| Dec 31, 2023 | 184,000.00 |
| Sep 30, 2023 | 121,000.00 |
| Jun 30, 2023 | 120,000.00 |
| Mar 31, 2023 | 118,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Sep 30, 2022 | 59,000.00 |
| Jun 30, 2022 | 92,000.00 |
| Mar 31, 2022 | 123,000.00 |
| Dec 31, 2021 | 120,000.00 |
| Sep 30, 2021 | 116,000.00 |
| Jun 30, 2021 | 111,000.00 |
| Mar 31, 2021 | 107,000.00 |
| Dec 31, 2020 | 113,000.00 |
| Sep 30, 2020 | 110,000.00 |
| Jun 30, 2020 | 106,000.00 |
| Mar 31, 2020 | 102,000.00 |
| Dec 31, 2019 | 99,000.00 |
| Sep 30, 2019 | 95,000.00 |
| Jun 30, 2019 | 91,000.00 |
| Mar 31, 2019 | 88,000.00 |